About this source
- Kind
- Research
- Design
- Human observational
- Population
- US adults exposed to teriparatide, followed in a post-marketing osteosarcoma surveillance study
- Primary or secondary
- primary
- Peer review
- peer reviewed
- Retraction status
- None known
- Date checked
- 14 November 2026
Limitations
Observational surveillance. Only 3 exposed cases were identified, so the confidence interval is wide and very rare effects cannot be excluded.
Cited in
Post-marketing osteosarcoma surveillance
Teriparatide · Safety finding
Spotted an error? Report a problem with this page. We correct the record and log every change on What's changed.